WO2002062355A3 - Hydriodic acid and iodide salts for treatment of male impotence - Google Patents

Hydriodic acid and iodide salts for treatment of male impotence Download PDF

Info

Publication number
WO2002062355A3
WO2002062355A3 PCT/US2002/003358 US0203358W WO02062355A3 WO 2002062355 A3 WO2002062355 A3 WO 2002062355A3 US 0203358 W US0203358 W US 0203358W WO 02062355 A3 WO02062355 A3 WO 02062355A3
Authority
WO
WIPO (PCT)
Prior art keywords
hydriodic acid
treatment
male impotence
iodide salts
male
Prior art date
Application number
PCT/US2002/003358
Other languages
French (fr)
Other versions
WO2002062355A2 (en
Inventor
Susann R Reilly
Original Assignee
Rainburst Llc
Susann R Reilly
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rainburst Llc, Susann R Reilly filed Critical Rainburst Llc
Publication of WO2002062355A2 publication Critical patent/WO2002062355A2/en
Publication of WO2002062355A3 publication Critical patent/WO2002062355A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for treating male impotence comprises orally administering to an impotent male subject an effective amount of (a) a pharmaceutically acceptable water soluble iodide salt which generates hydriodic acid in situ or (b) an aqueous solution of hydriodic acid.
PCT/US2002/003358 2001-02-07 2002-02-07 Hydriodic acid and iodide salts for treatment of male impotence WO2002062355A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26684801P 2001-02-07 2001-02-07
US60/266,848 2001-02-07

Publications (2)

Publication Number Publication Date
WO2002062355A2 WO2002062355A2 (en) 2002-08-15
WO2002062355A3 true WO2002062355A3 (en) 2003-02-06

Family

ID=23016231

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/003358 WO2002062355A2 (en) 2001-02-07 2002-02-07 Hydriodic acid and iodide salts for treatment of male impotence

Country Status (1)

Country Link
WO (1) WO2002062355A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO94261A2 (en) * 1986-01-03 1988-04-30 Intreprinderea De Medicamente"Terapia",Ro MEDICAL PRODUCT FOR SEXUAL DYNAMIC DISORDERS
US5281423A (en) * 1992-04-02 1994-01-25 Reilly Susann R Use of hydriodic acid as an aphrodisiac
WO2002024210A2 (en) * 2000-09-19 2002-03-28 Robert Edward Chapman Halogen compounds for use in medicine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO94261A2 (en) * 1986-01-03 1988-04-30 Intreprinderea De Medicamente"Terapia",Ro MEDICAL PRODUCT FOR SEXUAL DYNAMIC DISORDERS
US5281423A (en) * 1992-04-02 1994-01-25 Reilly Susann R Use of hydriodic acid as an aphrodisiac
US5470588A (en) * 1992-04-02 1995-11-28 Reilly; Susann R. Method of increasing vaginal lubrication
WO2002024210A2 (en) * 2000-09-19 2002-03-28 Robert Edward Chapman Halogen compounds for use in medicine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 198834, Derwent World Patents Index; Class B01, AN 1988-240790, XP002216669 *

Also Published As

Publication number Publication date
WO2002062355A2 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
AU2001232735A1 (en) Process for solubilizing glucagon-like peptide 1 compounds
EP2253309A3 (en) Gastric acid secretion inhibiting composition
EP1243269A3 (en) Opioid formulations having extended controlled release
WO2002022598A8 (en) Quinolinone derivatives as tyrosine kinase inhibitors
WO2002004361A8 (en) System and method for simultaneous removal of arsenic and fluoride from aqueous solutions
WO2003002243A3 (en) Method and device for electrochemical formation of therapeutic species in vivo
WO2005115416A3 (en) Method of treating with chlorine dioxide
HUP0202749A2 (en) Pharmaceutical solutions of levosimendan
EP0838225A3 (en) Aqueous local anesthetic solution
EP0951908A3 (en) Method of treating impotence due to spinal cord injury
WO2002062355A3 (en) Hydriodic acid and iodide salts for treatment of male impotence
ATE474552T1 (en) SOLID DOSAGE FORM FOR THE EYE APPLICATION OF AN ACTIVE SUBSTANCE, SOLUBLE, SOLID OPHTHALMIC INSERT AND PRODUCTION METHOD THEREOF
WO2002069989A3 (en) Aquatic animal treatment method and composition containing pimenta extract
MY122477A (en) Sertraline oral concentrate
WO2002060459A3 (en) Use of iodide salt as an aphrodisiac
WO2002051400A3 (en) Solid dosage forms of divalproex sodium
US20070293543A1 (en) THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC pH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-Z
EP1228761A3 (en) Liquid pharmaceutical composition for treating bone diseases
NZ513869A (en) Use of moxonidine for postmyocardial infarction treatment
RU99118938A (en) METHOD FOR TREATING AN EXCELLENCE OF CHRONIC PANCREATITIS
WO2002081020A3 (en) Method for preventing acute renal failure
EP0267442B1 (en) Tetrazolylquinazolinones as anti-hyperuricemic agents
CA2308660A1 (en) Stable aqueous pharmaceutical composition comprising tezosentan
JPS57118510A (en) Method of increasing absorption of membrane-absorptive preparation on administration
UA42947A (en) Method for treating generalized severe periodontitis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP